Cargando…
复发/难治多发性骨髓瘤患者嵌合抗原受体T细胞治疗后造血恢复情况及影响因素分析
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669621/ https://www.ncbi.nlm.nih.gov/pubmed/36709201 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.10.010 |
| _version_ | 1784832141538885632 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9669621 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Editorial office of Chinese Journal of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96696212022-11-18 复发/难治多发性骨髓瘤患者嵌合抗原受体T细胞治疗后造血恢复情况及影响因素分析 Zhonghua Xue Ye Xue Za Zhi 短篇论著 Editorial office of Chinese Journal of Hematology 2022-10 /pmc/articles/PMC9669621/ /pubmed/36709201 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.10.010 Text en 2022年版权归中华医学会所有 https://creativecommons.org/licenses/by/3.0/This work is licensed under a Creative Commons Attribution 3.0 License. |
| spellingShingle | 短篇论著 复发/难治多发性骨髓瘤患者嵌合抗原受体T细胞治疗后造血恢复情况及影响因素分析 |
| title | 复发/难治多发性骨髓瘤患者嵌合抗原受体T细胞治疗后造血恢复情况及影响因素分析 |
| title_full | 复发/难治多发性骨髓瘤患者嵌合抗原受体T细胞治疗后造血恢复情况及影响因素分析 |
| title_fullStr | 复发/难治多发性骨髓瘤患者嵌合抗原受体T细胞治疗后造血恢复情况及影响因素分析 |
| title_full_unstemmed | 复发/难治多发性骨髓瘤患者嵌合抗原受体T细胞治疗后造血恢复情况及影响因素分析 |
| title_short | 复发/难治多发性骨髓瘤患者嵌合抗原受体T细胞治疗后造血恢复情况及影响因素分析 |
| title_sort | 复发/难治多发性骨髓瘤患者嵌合抗原受体t细胞治疗后造血恢复情况及影响因素分析 |
| topic | 短篇论著 |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669621/ https://www.ncbi.nlm.nih.gov/pubmed/36709201 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.10.010 |
| work_keys_str_mv | AT fùfānánzhìduōfāxìnggǔsuǐliúhuànzhěqiànhékàngyuánshòutǐtxìbāozhìliáohòuzàoxuèhuīfùqíngkuàngjíyǐngxiǎngyīnsùfēnxī AT fùfānánzhìduōfāxìnggǔsuǐliúhuànzhěqiànhékàngyuánshòutǐtxìbāozhìliáohòuzàoxuèhuīfùqíngkuàngjíyǐngxiǎngyīnsùfēnxī AT fùfānánzhìduōfāxìnggǔsuǐliúhuànzhěqiànhékàngyuánshòutǐtxìbāozhìliáohòuzàoxuèhuīfùqíngkuàngjíyǐngxiǎngyīnsùfēnxī AT fùfānánzhìduōfāxìnggǔsuǐliúhuànzhěqiànhékàngyuánshòutǐtxìbāozhìliáohòuzàoxuèhuīfùqíngkuàngjíyǐngxiǎngyīnsùfēnxī AT fùfānánzhìduōfāxìnggǔsuǐliúhuànzhěqiànhékàngyuánshòutǐtxìbāozhìliáohòuzàoxuèhuīfùqíngkuàngjíyǐngxiǎngyīnsùfēnxī AT fùfānánzhìduōfāxìnggǔsuǐliúhuànzhěqiànhékàngyuánshòutǐtxìbāozhìliáohòuzàoxuèhuīfùqíngkuàngjíyǐngxiǎngyīnsùfēnxī AT fùfānánzhìduōfāxìnggǔsuǐliúhuànzhěqiànhékàngyuánshòutǐtxìbāozhìliáohòuzàoxuèhuīfùqíngkuàngjíyǐngxiǎngyīnsùfēnxī AT fùfānánzhìduōfāxìnggǔsuǐliúhuànzhěqiànhékàngyuánshòutǐtxìbāozhìliáohòuzàoxuèhuīfùqíngkuàngjíyǐngxiǎngyīnsùfēnxī AT fùfānánzhìduōfāxìnggǔsuǐliúhuànzhěqiànhékàngyuánshòutǐtxìbāozhìliáohòuzàoxuèhuīfùqíngkuàngjíyǐngxiǎngyīnsùfēnxī |